The financial services provider reported a net profit of A$3.715 billion for the year ended 31 March (FY25), this being a 5% increase from the prior comparable period (FY24).

Macquarie told investors that its profit performance in the second half of FY25 had also been stronger, coming in at $2.10 billion: a rise of 30% compared to the first half of FY25.

The business was also bolstered by a rise of 2% in net operating income for FY25, which was $17.208 billion, while operating expenses were also strong, at $12,140 billion: close to what had been reported for the prior reporting period.

Its final ordinary dividend was reported as $3.90 per share – of which 35% was franked – with the ordinary dividend for FY25 being $6.50 per share (also 35% franked), this representing a 2H25 payout ratio of 71% and FY25 payout ratio of 67%.

Also in FY25, Macquarie reported a net operating income of $A17.208 billion: this being up 2% per cent on FY24, while operating expenses of $A12.140 billion were close to the numbers for FY24. International income accounted for 66 per cent of Macquarie’s total income.

Managing director and CEO Shemara Wikramanayake said these figures showed the company in a strong position despite external headwinds.

“Against a backdrop of ongoing market and economic uncertainty, Macquarie’s client franchises remained resilient over the past year, delivering new business origination and underlying income growth, contributing to our history of unbroken profitability,” she said.

Macquarie Group has been trading at $195.89.

Join the discussion: See what HotCopper users are saying about MQG and be part of the conversations that move the markets.

Capitol told investors that its underlying NPAT (net profit after tax) for the 2024 fiscal year had increased by a quarter of a percent (25%) to $11 million compared to the previous year, while revenue had also grown for the same period, by 12% to $238 million.

In a year when Capitol had announced a proposed merger with Integral Diagnostics Limited (ASX:IDX) and opened new MRI comprehensive clinic at Sunshine Private Hospital in Victoria, the company said its final dividend for FY2024 would be declared in line with merger ratio (with this being 0.12849 of the FY2024 final dividend of IDX).

Meanwhile, Genesis Energy Ltd (ASX:GNE) posted a significant fall in profit during the 12-month period to June 2024.

In its full statutory accounts, Genesis said its net profit was down 33% to $131.1 million compared to $195.8 million in the previous fiscal year.

This was also reflected in the company’s EBITDAF (earnings before interest, tax, depreciation, amortisation, fair value movements of financial instruments, investment costs, realisations and impairments), which came in at $407.2 million in FY2024, a fall of 22% from the figure of $523.5 million in FY2023.

Genesis said its ‘strategy was on track despite a challenging year’ impacted by constraints in gas supply, low hydro and wind levels, and a 7-month outage at Huntly Unit 5.

Its total dividends per share for FY2024 were 14 cps, compared to 17.6 cps in FY2023, a fall of 21%.

An annual report was also out from casino operator SkyCity Entertainment Group Ltd (ASX:SKC), who said that underlying group NPAT had fallen 7.2% TO NZ$123.2 million, reflecting lower earnings.

EBITDA was also down 8% to NZ$277.8 million, and CEO Jason Walbridge said the weaker figures overall were underpinned by cost-of-living pressures, a softer economy, and SkyCity’s requirement to respond to certain regulatory issues.

SkyCity previously announced that it would be closing gambling operations at its Auckland site for five days next month, and this was set to cost the company NZ$5 million in expected earnings for FY2025.

The decision was made as part of an agreement between management and the Secretary of Internal Affairs in order to avoid the temporary suspension of the company’s casino operator’s licence.

Underlying earnings per share were 16.2 cps for FY2024, a fall of 7.3% year on year.

Medibank Private Ltd (ASX:MPL) reported a strong suite of results today, with underlying NPAT coming in at $570.4 million for the 2024 fiscal year: a rise of 14.1% from the previous reporting period.

CEO David Koczkar said the priority for Medibank had been on keeping premiums low and providing support for customers, as reflected in a $305 million COVID give back, which brought total customer support to a record $1.46 billion during the period.

The company’s final ordinary dividend (fully franked) was 9.4 cps.

At 12:11 AEST, Medibank shares were down 1.5% at $3.88, SkyCity shares were down 2.41% at $1.42, shares in Genesis Energy had risen 0.48% to $2.08, and Capitol Health shares were 4.24% higher at 31 cents.